Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP447529.RAmXoS5Y83n_xMYh5Bx8DyJp5ydCxMz_lfvyVafqOsG7Y130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP447529.RAmXoS5Y83n_xMYh5Bx8DyJp5ydCxMz_lfvyVafqOsG7Y130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP447529.RAmXoS5Y83n_xMYh5Bx8DyJp5ydCxMz_lfvyVafqOsG7Y130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP447529.RAmXoS5Y83n_xMYh5Bx8DyJp5ydCxMz_lfvyVafqOsG7Y130_provenance.
- NP447529.RAmXoS5Y83n_xMYh5Bx8DyJp5ydCxMz_lfvyVafqOsG7Y130_assertion description "[Our aim was to determine the expression of c-Met, its ligand hepatocyte growth factor/scatter factor (HGF/SF) and Her2/neu in ductal carcinoma in situ (DCIS) lesions of the breast (n = 39) by two different immunocytochemical techniques, classical immunohistochemistry and immunofluorescence, and to correlate their expression levels with histopathological and clinical characteristics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP447529.RAmXoS5Y83n_xMYh5Bx8DyJp5ydCxMz_lfvyVafqOsG7Y130_provenance.
- NP447529.RAmXoS5Y83n_xMYh5Bx8DyJp5ydCxMz_lfvyVafqOsG7Y130_assertion evidence source_evidence_literature NP447529.RAmXoS5Y83n_xMYh5Bx8DyJp5ydCxMz_lfvyVafqOsG7Y130_provenance.
- NP447529.RAmXoS5Y83n_xMYh5Bx8DyJp5ydCxMz_lfvyVafqOsG7Y130_assertion SIO_000772 17593080 NP447529.RAmXoS5Y83n_xMYh5Bx8DyJp5ydCxMz_lfvyVafqOsG7Y130_provenance.
- NP447529.RAmXoS5Y83n_xMYh5Bx8DyJp5ydCxMz_lfvyVafqOsG7Y130_assertion wasDerivedFrom befree-20150227 NP447529.RAmXoS5Y83n_xMYh5Bx8DyJp5ydCxMz_lfvyVafqOsG7Y130_provenance.
- NP447529.RAmXoS5Y83n_xMYh5Bx8DyJp5ydCxMz_lfvyVafqOsG7Y130_assertion wasGeneratedBy ECO_0000203 NP447529.RAmXoS5Y83n_xMYh5Bx8DyJp5ydCxMz_lfvyVafqOsG7Y130_provenance.
- befree-20150227 importedOn "2015-02-27" NP447529.RAmXoS5Y83n_xMYh5Bx8DyJp5ydCxMz_lfvyVafqOsG7Y130_provenance.